-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 L2dT3LXWzgABWhX68U1/peql6APJ5pEl3K//fviUFqN1+BrIDcUEQz3SaCTBFvig
 mumTZBfmfq0g1r4lm0+5nA==

<SEC-DOCUMENT>0000200406-06-000109.txt : 20061031
<SEC-HEADER>0000200406-06-000109.hdr.sgml : 20061031
<ACCEPTANCE-DATETIME>20060802114729
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000200406-06-000109
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20060802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>




                       August 2, 2006

Mr. Jim B. Rosenberg
Senior Assistant Chief Accountant
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549

Re:  Johnson & Johnson
     Form 10-K for Fiscal Year Ended January 1, 2006
     File No. 1-03215

Dear Mr. Rosenberg:

On July 25, 2006, in a phone conference with Mr. Mark
Brunhofer, we discussed four follow-up requests to our
response to your letter of May 31, 2006.  The items were as
follows:

1. Relocate Schedule II - Valuation and Qualifying Accounts
currently included in the Form 10-K to Management's
Discussion and Analysis of Results of Operations and
Financial Condition in the Annual Report.

2. Disaggregate the accrued rebates, returns and promotions
line within Schedule II to three distinct line items.

3. Enhance the disclosure of sales returns allowances within
Management's Discussion and Analysis of Results of
Operations and Financial Condition.

4. Include an assertion regarding the impact that reasonably
likely changes to our assumptions could have on our
financial statements.

Our response to these items is as follows:

1.  We will include Schedule II type disclosure- Valuation
and Qualifying Accounts within Management's Discussion and
Analysis of Results of Operations and Financial condition
beginning with the fiscal year ended December 31, 2006 and
for all subsequent year end filings.  This schedule will be
included by segment for the current year and the prior year.
A summary schedule for our three segments of business in the
aggregate for the current year and 2 prior years will
continue to be included as Schedule II in our Form 10-K.

2. We will disaggregate the accrued rebates, returns and
promotions line into three distinct line items in both the
segment disclosure within Management's Discussion and
Analysis of Results of Operations and Financial Condition
and the summary schedule appearing as Schedule II within the
Form 10-K.  We will include this beginning with the fiscal
year ended December 31, 2006 and for all subsequent year end
filings.

3. Beginning in our Form 10-K for the fiscal year ended
December 31, 2006, the disclosure of sales returns
allowances will be enhanced to include the following
language:

Sales Returns Allowances represent a reserve for products
that may be returned due to expiration, destruction in the
field, or in specific areas, product recall.  The returns
reserve is based on historical return trends by product and
by market as a percent to gross sales.  We will also include
the balance of the reserve for sales returns by segment for
the current year and prior year end.

4.  Beginning in our Form 10-K for the fiscal year ended
December 31, 2006, we will include an assertion regarding
the impact that reasonably likely changes to our assumptions
could have on our financial statements.

If you have any questions or comments, please call me at
(732) 524-3737 or Phil Savas, Assistant Corporate
Controller, Financial Reporting and Analysis at (732) 524-
3566.

                                        Sincerely,



                                        Stephen J. Cosgrove


cc:  W. C. Weldon
     R. J. Darretta
     S. M. Rosenberg
     P. A. Savas


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
